Since their introduction in the mid 1970s syringe drivers have provided symptom control via subcutaneous infusions of drugs to treat unrelieved pain and other distressing symptoms when other routes are inappropriate or no longer effective. The Graseby MS16A (introduced in 1976) and MS26 (introduced in 1983) syringe drivers have been a mainstay of palliative care provision across Australia for more than twenty years.
Following the withdrawal from sale of the Graseby syringe drivers, Palliative Care Australia in collaboration with the Centre for Palliative Care Research and Education have prepared this report to help inform the palliative care and aged care sectors about alternative devices that are available to the Australian market.
To access the full report CLICK HERE
To access Appendix 1 – the manufacturers’ responses to the criteria defined by the aged care and palliative care sectors CLICK HERE
